Scans to screen all 40M Americans with diabetes for HF would be nearly impossible, but the TARTAN-HF trial may have found a more streamlined method by leveraging the cardiometabolic connection. Which is why TARTAN-HF’s researchers created a targeted screening strategy. Spoiler alert: the method worked. Among 706 patients with diabetes randomized to usual care or […] The post TARTAN-HF’s Targeted Tests for Diabetes Patients appeared first on Cardiac Wire .
TARTAN-HF’s Targeted Tests for Diabetes Patients
Virginia Hunt